Behnood Bikdeli/massgeneralbrigham.org
Oct 18, 2026, 07:05
Behnood Bikdeli: Vasculearn Network Highlights Expert Perspectives on PE Risk Stratification and Advanced Therapies
Behnood Bikdeli, Cardiologist and Vascular Medicine Specialist at Brigham and Women’s Hospital and Harvard Medical School, shared a post on X:
“Seeking a rigorous discussion on PE risk stratification and advanced therapies?
Honored to moderate a Vasculearn Network panel with Mass General Brigham, The New England Journal of Medicine’s Jane Leopold, CHEST Journal’s Lisa Moores and WashU Medicine Mallinckrodt Institute of Radiology’s Suresh Vedantham.”
Stay updated with Hemostasis Today.
-
Oct 18, 2026, 06:27Gregory Makris: NEJM Study Supports Earlier Catheter-Directed Intervention in Intermediate-High–Risk PE
-
Oct 18, 2026, 06:26Danny Hsu: BLOOD 2026 Return to Aotearoa
-
Oct 18, 2026, 02:43Priya Sriskandarajah: Diagnosis and Management of PV and JAK2-Unmutated Erythrocytosis
-
Oct 18, 2026, 02:41C. Michael Gibson: A Meta-Analysis of DOACs and DAPT After Left Atrial Appendage Closure
-
Oct 18, 2026, 02:27What Hematologists Should Remember About the Person Behind the Platelet Count – ASH
-
Oct 18, 2026, 01:44Marta Velia Antonini: How to Deliver CRRT during ECMO?
-
Oct 18, 2026, 01:19Aamir Saeed: Anticoagulation, Cirrhosis, and Other Risk Factors for Post-ERCP Bleeding
-
Oct 18, 2026, 00:33Elad Asher: Does Opening the Clot Change How a Patient Feels Three Months Later?
-
Oct 18, 2026, 00:22Richa Sharma: Evaluating Heterogeneity in Anticoagulation Treatment Effects in Cryptogenic Stroke